MAPT and Alzheimer disease: 3xTgAD mice with a 50% reduction of Polβ (3xTg AD/Polβ+/−), which also contain a mutated version of human tau, display exacerbated AD phenotypes with impaired cellular bioenergetics and mitochondrial dysfunction [58, 77].